In the News January 20, 2016

Bloomberg BNA | Outlook 2016: Lab Tests, Cybersecurity, Off-Label Use Among Top Device Issues

Peter Kazon is quoted on the Food and Drug Administration’s focus to regulate laboratory-developed tests (LDTs) amid uncertainty over the agency’s final LDT guidance.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.